Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes.
Regarding abuse in patients with RD, there is little information in the literature; however, it is possible that the prevalence could be similar to that of the occurrence in older adults since both populations share important states of vulnerability.
The study aimed to identify the prevalence of abuse in patients with RD. The study will be conducted in two phases: the first one in which the GAS will be adapted for patients with RD, and this version will be validated in a population of our Institute, and the second one in which, applying the validated instrument, the magnitude of abuse is evaluated, and the factors associated with this phenomenon among patients with RD are explored.
Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes.
In 1970, the phenomenon of abuse in geriatric patients was described for the first time as a phenomenon identified as a public health problem and an issue of human rights violation.
In 2012 Giraldo-RodrÃguez developed and validated the Geriatric Abuse Scale (GAS), an instrument that, with adequate psychometric properties, reported a prevalence of abuse of 10.28% in Mexico.
Regarding abuse in patients with RD, there is little information in the literature; however, it is possible that the prevalence could be similar to that of the occurrence in older adults since both populations share important states of vulnerability.
The study aimed to identify the prevalence of abuse in patients with RD. The study will be conducted in two phases: the first one in which the GAS will be adapted for patients with RD, and this version will be validated in a population of our Institute, and the second one in which, applying the validated instrument, the magnitude of abuse is evaluated, and the factors associated with this phenomenon among patients with RD are explored.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with rheumatic diseases | All the rheumatic diseases outpatients from the National Institute of Medical Sciences |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Rheumatic diseases Mistreatment Scale (RDMS) | Other | In 2012 Giraldo-RodrÃguez developed and validated the Geriatric Mistreatment Scale (GAS), prior to its application, translation, cultural adaptation, and validation were performed. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Mexican patients with RD who will present the phenomenon of mistreatment | Identify the percentage of patients with rheumatic diseases that present mistreatment using the instrument developed by Giraldo-RodrÃguez et al (translation, cultural adaptation, and validation performed) | At inclusion (baseline moment) (cross-sectional study) |
| Measure | Description | Time Frame |
|---|---|---|
| Identify factors associated with mistreatment among patients with rheumatic diseases | Identify factors associated with mistreatment among patients with rheumatic diseases using an instrument locally development | At inclusion (baseline moment) (cross-sectional study) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
All the rheumatic diseases outpatients from the National Institute of Medical Sciences
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Virginia Ph Pascual-Ramos | Contact | 525555734111 | 533 | virtichu@gmail.com |
| Virginia Dr Pascual-Ramos | Contact | 525555734111 | 533 | virtichu@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Virginia Dr Pascual-Ramos | INNSZ | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán | Recruiting | Mexico City | 14080 | Mexico |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 22694594 | Background | Giraldo-Rodriguez L, Rosas-Carrasco O. Development and psychometric properties of the Geriatric Mistreatment Scale. Geriatr Gerontol Int. 2013 Apr;13(2):466-74. doi: 10.1111/j.1447-0594.2012.00894.x. Epub 2012 Jun 14. | |
| 16357732 | Background | Castro I, Barrantes F, Tuna M, Cabrera G, Garcia C, Recinos M, Espinoza LR, Garcia-Kutzbach A. Prevalence of abuse in fibromyalgia and other rheumatic disorders at a specialized clinic in rheumatic diseases in Guatemala City. J Clin Rheumatol. 2005 Jun;11(3):140-5. doi: 10.1097/01.rhu.0000164823.78761.a2. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Health Assessment Questionnaire (HAQ) | Other | The HAQ is based on five patient-centered dimensions: disability, pain, medication effects, costs of care, and mortality |
|
|
| Depression, Anxiety and Stress Scale (DASS-21) | Other | DASS-21 is a set of three self-report scales designed to measure the emotional states of depression, anxiety, and stress. Each of the three DASS-21 scales contains 7 items, divided into subscales with similar content |
|
|
| Brief Resilient Coping Scale | Other | Brief Resilient Coping Scale is a 4-item measure designed to capture tendencies to cope with stress in a highly adaptive manner |
|
|
| WHOQOL-BREF | Other | WHOQOL-BREF is a 26-item instrument consisting of four domains: physical health, psychological health, social relationships, and environmental health; it also contains QOL and general health items |
|
| Routine assessment of patient index data 3 (RAPID-3) | Other | RAPID- 3 measures: function, pain, and patient global estimate of status. Each of the 3 individual measures is scored 0 to 10, for a total of 30 |
|
|
| Big Five Inventory | Other | The BFI-10 is a 10-item scale measuring the Big Five personality traits Extraversion, Agreeableness, Conscientiousness, Emotional Stability, and Openness. |
|
|
| Family APGAR Questionnaire | Other | Family APGAR questionnaire is used to evaluate family function, in the context of family medical care |
|
|
| 39775374 | Derived | Contreras-Yanez I, Ledon-LLanes L, Guaracha-Basanez GA, Sanchez-Hernandez A, Ortiz-Haro AB, Pascual-Ramos V. Perceived mistreatment in patients with rheumatic diseases: The impact of the underlying diagnosis. PLoS One. 2024 Dec 30;19(12):e0316312. doi: 10.1371/journal.pone.0316312. eCollection 2024. |
| ID | Term |
|---|---|
| D012216 | Rheumatic Diseases |
| ID | Term |
|---|---|
| D009140 | Musculoskeletal Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C020182 | ametantrone |
Not provided
Not provided
Not provided